Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data

Bo Peng,Xiaohui Yao,Shannon L. Risacher,Andrew J. Saykin,Li Shen,Xia Ning,

DOI: https://doi.org/10.1186/s12911-020-01339-z

IF: 3.298

2020-12-01

BMC Medical Informatics and Decision Making

Abstract:Abstract Background Cognitive assessments represent the most common clinical routine for the diagnosis of Alzheimer’s Disease (AD). Given a large number of cognitive assessment tools and time-limited office visits, it is important to determine a proper set of cognitive tests for different subjects. Most current studies create guidelines of cognitive test selection for a targeted population, but they are not customized for each individual subject. In this manuscript, we develop a machine learning paradigm enabling personalized cognitive assessments prioritization. Method We adapt a newly developed learning-to-rank approach $${\mathtt {PLTR}}$$ PLTR to implement our paradigm. This method learns the latent scoring function that pushes the most effective cognitive assessments onto the top of the prioritization list. We also extend $${\mathtt {PLTR}}$$ PLTR to better separate the most effective cognitive assessments and the less effective ones. Results Our empirical study on the ADNI data shows that the proposed paradigm outperforms the state-of-the-art baselines on identifying and prioritizing individual-specific cognitive biomarkers. We conduct experiments in cross validation and level-out validation settings. In the two settings, our paradigm significantly outperforms the best baselines with improvement as much as 22.1% and 19.7%, respectively, on prioritizing cognitive features. Conclusions The proposed paradigm achieves superior performance on prioritizing cognitive biomarkers. The cognitive biomarkers prioritized on top have great potentials to facilitate personalized diagnosis, disease subtyping, and ultimately precision medicine in AD.

medical informatics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to individually and preferentially rank cognitive assessment tools based on the brain MRI data of individual patients in the diagnosis of Alzheimer's disease (AD). Specifically, the researchers have developed a machine - learning paradigm, using the Learning - to - Rank (LETOR) method, especially PLTR (Push and Learning - to - Rank) and its extended version PLTRh, to identify and preferentially rank individual - specific cognitive biomarkers related to AD. This method aims to overcome the limitations in existing research, that is, most studies only develop cognitive test selection guidelines for specific populations and fail to customize for each individual patient.

Through this method, the researchers hope to achieve the following goals:
1. **Personalized diagnosis**: Recommend the most effective cognitive assessment tools according to the specific situation of each patient, thereby improving the accuracy and efficiency of diagnosis.
2. **Disease subtype classification**: By identifying the key cognitive features related to different AD subtypes, it is helpful to classify the disease more precisely.
3. **Precision medicine**: Ultimately promote precision medicine for Alzheimer's disease and provide more personalized treatment plans for each patient.

The paper experimentally verified the effectiveness of the proposed method, and the results showed that PLTR and PLTRh are significantly superior to the existing baseline methods in identifying and preferentially ranking individual - specific cognitive biomarkers.